Milestone Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 3 professional analysts, the 12-month price target for Milestone Pharmaceuticals stock ranges from a low of $4.00 to a high of $10. The average analyst price target of $6.33 forecasts a 216.50% increase in the stock price over the next year.

Price Target: $6.33 (+216.50%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$6.33	$5.00	$10
Change	+100.00%	+216.50%	+150.00%	+400.00%

Analyst Ratings

The average analyst rating for Milestone Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mohit Bansal Wells Fargo	Wells Fargo	Buy Initiates $4	Buy	Initiates	$4	+100.00%	Sep 11, 2025
Brandon Folkes HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $5	Strong Buy	Initiates	$5	+150.00%	Jun 5, 2025
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $25 → $10	Strong Buy	Maintains	$25 → $10	+400.00%	Apr 1, 2025
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $25	Strong Buy	Reiterates	$25	+1,150.00%	Mar 28, 2025
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $25	Strong Buy	Reiterates	$25	+1,150.00%	Mar 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

28.79M

EPS This Year

-0.82

from -0.67

EPS Next Year

-0.94

from -0.82

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	15.00M	5.00M	1.00M	-	-	28.79M
Revenue Growth	-	-	-66.67%	-80.00%	-	-	-
EPS	-1.70	-1.02	-1.38	-1.39	-0.67	-0.82	-0.94
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	92.9M
Avg	n/a	28.8M
Low	n/a	2.4M

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-0.77	-0.66
Avg	-0.82	-0.94
Low	-0.83	-1.45

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.